R-pharm International, Llc
Clinical trials sponsored by R-pharm International, Llc, explained in plain language.
-
New drug could ease painful muscle condition and cut steroid use
Disease control OngoingThis phase 3 trial tests a biologic drug called olokizumab in 125 people with polymyalgia rheumatica, a condition causing muscle pain and stiffness. The drug is given as a shot every two weeks. The main goal is to see if it can control symptoms and allow patients to take lower do…
Phase: PHASE3 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: RS-113 under study
Disease control OngoingThis phase 2 trial is testing three different doses of a new drug called RS-113 in 120 men with metastatic castration-resistant prostate cancer, a type that has spread and no longer responds to standard hormone therapy. The study compares RS-113 to the current drug abiraterone to…
Phase: PHASE2 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC